Liaquat National Hospital

FDA Approves Innovative 4D Flow MRI Blood Flow Analysis Software from Cardio Flow Design Inc. (Japan) - Enhance Cardiovascular Diagnostic Accuracy

Retrieved on: 
Monday, June 19, 2023

The FDA approval is significant as it recognizes the safety and effectiveness of iTFlow® in analyzing blood flow through 4D Flow MRI data, with the potential to enhance diagnostic accuracy for patients with cardiovascular diseases and heart conditions.

Key Points: 
  • The FDA approval is significant as it recognizes the safety and effectiveness of iTFlow® in analyzing blood flow through 4D Flow MRI data, with the potential to enhance diagnostic accuracy for patients with cardiovascular diseases and heart conditions.
  • iTFlow® is an innovative software solution developed by Cardio Flow Design Inc. that supports blood flow analysis and evaluation in the fields of cardiovascular surgery and radiology.
  • Based on MRI data, users can perform their own analysis and visualization of blood flow.
  • We have been pursuing the concept of blood flow analysis with 4D flow MRI for many years, and iTFlow® encapsulates the essence of this concept.

American College of Lifestyle Medicine's Health Equity Initiative Expands Priorities to Include Federally Qualified Health Centers

Retrieved on: 
Thursday, March 30, 2023

ST. LOUIS, March 30, 2023 /PRNewswire-PRWeb/ -- The American College of Lifestyle Medicine's (ACLM) HEAL (Health Equity Achieved through Lifestyle Medicine) Initiative announced today an additional strategic priority to continue addressing the needs of historically underserved groups that are at a higher risk for chronic disease. Effective April 1, 2023, HEAL leadership will add a focus on integrating lifestyle medicine into Federally Qualified Health Centers (FQHCs) and Community Health Centers (CHCs).

Key Points: 
  • ST. LOUIS, March 30, 2023 /PRNewswire-PRWeb/ -- The American College of Lifestyle Medicine's (ACLM) HEAL (Health Equity Achieved through Lifestyle Medicine) Initiative announced today an additional strategic priority to continue addressing the needs of historically underserved groups that are at a higher risk for chronic disease.
  • Effective April 1, 2023, HEAL leadership will add a focus on integrating lifestyle medicine into Federally Qualified Health Centers (FQHCs) and Community Health Centers (CHCs).
  • An important element of this new strategy is ACLM's 5.5-hour CME/CE-accredited complimentary course, "Introduction to Lifestyle Medicine & Food as Medicine Essentials" course bundle.
  • Each leader has laudable experience and has demonstrated their passion for health equity and lifestyle medicine.

FSD Pharma Inc Incorporates New Subsidiary to Capitalize on Drug Development Incentives in Australia

Retrieved on: 
Monday, January 9, 2023

“We are excited about the incorporation of FSD Pharma Australia, where we have an excellent opportunity to advance our pipeline,” said Mr. Zeeshan Saeed, President of FSD Pharma.

Key Points: 
  • “We are excited about the incorporation of FSD Pharma Australia, where we have an excellent opportunity to advance our pipeline,” said Mr. Zeeshan Saeed, President of FSD Pharma.
  • “Australia is a hotbed for clinical stage biotech companies, and our drug development programs will be able to take advantage of facilities offered by various government incentives in Australia,” added Mr. Saeed.
  • Chataway, Dhanda and Lê have agreed to join our international panel to contribute to our current and new programs,” said Dr. Lakshmi Kotra, CEO of Lucid Psycheceuticals, a wholly owned subsidiary of FSD Pharma.
  • Dr. Chataway received his Bachelor of Medicine & Surgery from Oxford University, and Doctor of Philosophy from Cambridge University.